Abstract
The factor VIII treatment history of non‐severe hemophilia A: COMMENT. Joint damage in adult patients with mild or moderate hemophilia A evaluated with the HEAD‐US system
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have